Health · 1 sources covering this

Researchers slow neurodegeneration in mice by barring T cells from the brain

A new study in mice led by Washington University in St. Louis researchers suggests that stopping certain immune cells from entering the brain could limit neurodegeneration.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·2h ago
Researchers slow neurodegeneration in mice by barring T cells from the brain
A new study in mice led by Washington University in St. Louis researchers suggests that stopping certain immune cells from entering the brain could limit neurodegeneration.
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/59fb2596adac251a98f129d02f30b560322db953"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Researchers slow neurodegeneration in mice by barring T cells from the brain"></iframe>

Researchers slow neurodegeneration in mice by barring T cells from the brain

How 1 sources are covering this

Researchers slow neurodegeneration in mice by barring T cells from the brain

More from Health

STAT+: AstraZeneca invests $2 billion in Summit Therapeutics

STAT+: Pharmalittle: We’re reading about Novo licensing a Chinese obesity pill, Merck pulling an antibiotic, and more

STAT+: UniQure’s gene therapy continues to slow Huntington’s progression after four years

After Failed Execution, Health Workers Say State’s Rules Flout Medical Ethics

Reader

Trust & legal

Across the network

How 1 sources are covering this

Researchers slow neurodegeneration in mice by barring T cells from the brain

More from Health

STAT+: AstraZeneca invests $2 billion in Summit Therapeutics

STAT+: Pharmalittle: We&#8217;re reading about Novo licensing a Chinese obesity pill, Merck pulling an antibiotic, and more

STAT+: UniQure&#8217;s gene therapy continues to slow Huntington&#8217;s progression after four years

After Failed Execution, Health Workers Say State’s Rules Flout Medical Ethics

Reader

Trust & legal

Across the network

STAT+: Pharmalittle: We’re reading about Novo licensing a Chinese obesity pill, Merck pulling an antibiotic, and more

STAT+: UniQure’s gene therapy continues to slow Huntington’s progression after four years